Results of tests conducted on the clinically isolated H1N1 virus from patients—the actual pandemic strain of the virus—demonstrate that the innovative composition completely deactivates the virus within 15 seconds of exposure. The tests were carried out in an FDA certified laboratory in the United States.
The novel product was invented by Professor Elka Touitou from the School of Pharmacy at HU and is being developed by Novel Therapeutic Technologies (NTT), a spin-off company of Yissum. “EtoClean appears to completely deactivate the swine flu virus almost immediately, while most hand sanitizers available on the market today were not tested specifically for swine flu,” says Yaacov Michlin, president and CEO of Yissum.
The new sanitizer has microbicidal and antiviral properties and is effective when used on skin, food, and a variety of surfaces. NTT is developing a full range of EtoClean-based sanitizing products in various pharmaceutical forms. EtoClean contains GRAS (Generally Regarded As Safe) ingredients, which are also environmentally friendly.
Photo by Business Wire |
It does not dry out the skin, even after frequent use. The product also “deactivates” many non-enveloped viruses, such as the hepatitis and noroviruses, which are not susceptible to regular alcohol-based sanitizers.
Sales of hand sanitizers have risen among the general population at pharmacies, supermarkets, and drugstores, as fear of swine flu grows, with the products growing into a US $200 million-a-year industry in the United States.
Excerpts from an article by www.israel21c.org
Photo Credit:
Photo Credit:
All logos and trademarks in this site are property of their respective owner. All other materials are property of Bridges for Peace. Copyright © 2024.
Website Site Design by J-Town Internet Services Ltd. - Based in Jerusalem and Serving the World.